Biotest AG
XETRA:BIO

Watchlist Manager
Biotest AG Logo
Biotest AG
XETRA:BIO
Watchlist
Price: 41.4 EUR Market Closed
Market Cap: 1.6B EUR
Have any thoughts about
Biotest AG?
Write Note

Wall Street
Price Targets

BIO Price Targets Summary
Biotest AG

There are no price targets for BIO.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Biotest AG Competitors:
Price Targets
CNTB
Connect Biopharma Holdings Ltd
651% Upside
ADMA
ADMA Biologics Inc
35% Upside
PAR
Paradigm Biopharmaceuticals Ltd
109% Upside
TWST
Twist Bioscience Corp
14% Upside
688428
InnoCare Pharma Ltd
40% Upside
358570
GI Innovation Inc
202% Upside
002007
Hualan Biological Engineering Inc
21% Upside
PRLD
Prelude Therapeutics Inc
292% Upside

Revenue
Forecast

Revenue Estimate
Biotest AG

For the last 8 years the compound annual growth rate for Biotest AG's revenue is 3%. The projected CAGR for the next 2 years is 2%.

3%
Past Growth
2%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Biotest AG

For the last 8 years the compound annual growth rate for Biotest AG's operating income is 16%. The projected CAGR for the next 2 years is -5%.

16%
Past Growth
-5%
Estimated Growth
Estimates Accuracy
-22%
Average Miss

Net Income
Forecast

Net Income Estimate
Biotest AG

The compound annual growth rate of Biotest AG's net income for the next 2 years is -32%.

N/A
Past Growth
-32%
Estimated Growth
Estimates Accuracy
1%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIO's stock price target?
Not Available

BIO doesn't have any price targets made by Wall Street professionals.

What is Biotest AG's Revenue forecast?
Projected CAGR
2%

For the last 8 years the compound annual growth rate for Biotest AG's revenue is 3%. The projected CAGR for the next 2 years is 2%.

What is Biotest AG's Operating Income forecast?
Projected CAGR
-5%

For the last 8 years the compound annual growth rate for Biotest AG's operating income is 16%. The projected CAGR for the next 2 years is -5%.

What is Biotest AG's Net Income forecast?
Projected CAGR
-32%

The compound annual growth rate of Biotest AG's net income for the next 2 years is -32%.

Back to Top